# Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease

Study · id `cardio:ct-nct01946815` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01946815](<https://clinicaltrials.gov/study/NCT01946815>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01946815

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 119 participants.

## Technical summary

Registry record NCT01946815. Allocation not applicable; no masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2018-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 119 participants (enrolled count; ClinicalTrials.gov record NCT01946815, source copy `cardio:ctgov-nct01946815-2023-04-12`, retrieved 2026-10-26)
- Start date: 2013-09 (registry gives no type) (ClinicalTrials.gov record NCT01946815, source copy `cardio:ctgov-nct01946815-2023-04-12`, retrieved 2026-10-26)
- Primary completion: 2018-11 (actual) (ClinicalTrials.gov record NCT01946815, source copy `cardio:ctgov-nct01946815-2023-04-12`, retrieved 2026-10-26)
- Completion: 2018-11 (actual) (ClinicalTrials.gov record NCT01946815, source copy `cardio:ctgov-nct01946815-2023-04-12`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT01946815, source copy `cardio:ctgov-nct01946815-2023-04-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01946815-2023-04-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease
- Acronym: FORTE
- Condition: Coronary Artery Disease
- Intervention (Drug): Atorvastatin
- Lead sponsor: Keimyung University Dongsan Medical Center
- Lead sponsor class: OTHER
- Collaborator: Seoul National University Hospital
- Collaborator class: OTHER
- Collaborator: Ulsan University Hospital
- Collaborator class: OTHER
- Collaborator: Inje University Ilsan Paik Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record: Atorvastatin (`cardio:atorvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: Keimyung University Dongsan Medical Center (`cardio:org-keimyung-university-dongsan-medical-center`)
- Registry lists this organization as a collaborator: Seoul National University Hospital (`cardio:org-seoul-national-university-hospital`)
- Registry lists this organization as a collaborator: Ulsan University Hospital (`cardio:org-ulsan-university-hospital`)
- Registry lists this organization as a collaborator: Inje University Ilsan Paik Hospital (`cardio:org-inje-university-ilsan-paik-hospital`)

## Provenance

Content hash: c06b9e2d1fc947454b674015dc652e3e5b412c39c771f747b1983c68cf9a0d7d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
